作者: Isabel Spriet , Wouter Meersseman , Liesbet Henckaerts , Willy Peetermans
关键词:
摘要: Posaconazole is a recently developed broad-spectrum triazole antifungal with potential for long-term prophylaxis or therapy of invasive fungal infections. This case illustrates the additive value therapeutic drug monitoring to guide clinical decision-making in high risk patients.